Reported Nov 29, 2023 · Ongoing

Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c…

Roche Diagnostics Operations, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Roche Diagnostics Operations, Inc. · 9115 Hague Rd · Indianapolis, IN · 46256-1025

Is this the product you have?

    • Tina-quant D-Dimer Test System
    • Fibrinogen/Fibrin Degradation Products Assay
    • Material Numbers 03001245322 - (cobas c 311
    • 501 and 502
    • INTEGRA 400 plus)
    • 08105618190 - (cobas c 303 and 503)
Lot codes and dates
  • All Lots Affected
  • UDI
    • 04015630914593 - (cobas c 311
    • 501 and 502
  • INTEGRA 400 plus) UDI07613336133651 - (cobas c 303 and 503)
Amount recalled
5,263 kits

Where it was sold

  • Nationwide

Why it was recalled

Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Roche Diagnostics Operations, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Data as of Sep 19, 4:52 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.